149 related articles for article (PubMed ID: 31413211)
1. [Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis].
Bu X; Qin A; Luo Z; Hu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):741-748. PubMed ID: 31413211
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer.
Chen W; Tu Q; Yu L; Xu Y; Yu G; Jia B; Cheng Y; Wang Y
Hum Cell; 2020 Oct; 33(4):1133-1141. PubMed ID: 32918700
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
4. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
5. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.
Yu Q; Guo K; Yang Y; Liu H; Huang Y; Li W
J Periodontal Res; 2024 Feb; 59(1):174-186. PubMed ID: 37957805
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
Chen Z; Tang W; Ye W; Song L; Chen Z
Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
12. Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation.
Lv C; Chen J; Huang F; Fang F; Li B
Toxicon; 2023 Jan; 222():106996. PubMed ID: 36535531
[TBL] [Abstract][Full Text] [Related]
13. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
[TBL] [Abstract][Full Text] [Related]
14. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.
Liu D; Wu K; Yang Y; Zhu D; Zhang C; Zhao S
Mol Carcinog; 2020 Jan; 59(1):32-44. PubMed ID: 31621118
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion.
Li H; Huang H; Li S; Mei H; Cao T; Lu Q
Exp Ther Med; 2021 Jun; 21(6):559. PubMed ID: 33850531
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
18. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
19. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
[TBL] [Abstract][Full Text] [Related]
20. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
Guo Q; Ni P; Dai Y; Hu J; Yao Y
J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
